Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio
27 févr. 2018 07h30 HE
|
Arch Biopartners
TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX-V:ARCH) (OTCBB:ACHFF) a portfolio-based biotechnology company, today announced CSBio of Menlo Park,...